As a first approach to test our translational hypothesis, and considering that VIP-induced decrease of the RANKL/OPG has been involved in its protective effect on bone destruction in the CIA model [36], we analyzed their serum levels in early arthritis patients clustered according to VIP serum levels. The gene discussed is TNFRSF11B; the disease is Arthritis.